Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
about
Non-traumatic coma in childrenEvidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasoneClinical characteristics and prognostic factors in childhood bacterial meningitis: a multicenter studyEpidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis.Diagnostic clinical and laboratory findings in response to predetermining bacterial pathogen: data from the Meningitis RegistryPneumococcal meningitis: clinical outcomes in a pre-vaccine era at a Dublin paediatric hospital, 1999-2007.Management of infections due to antibiotic-resistant Streptococcus pneumoniaeBMS-284756 in experimental cephalosporin-resistant pneumococcal meningitis.Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis.Josef Brudzinski and Vladimir Mikhailovich Kernig: signs for diagnosing meningitis.The impact of penicillin resistance on the outcome of invasive Streptococcus pneumoniae infection in children.The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal diseaseClinical outcome of pneumococcal meningitis during the emergence of pencillin-resistant Streptococcus pneumoniae: an observational study.Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland.Current pharmacotherapy of pneumococcal meningitis.Etiology of invasive bacterial infections in immunocompetent children in Korea (1996-2005): a retrospective multicenter study.New therapies and vaccines for bacterial meningitis.The emergence of resistant pneumococcal meningitis--implications for empiric therapy.Reprogramming the host response in bacterial meningitis: how best to improve outcome?Twenty year surveillance of invasive pneumococcal disease in Nottingham: serogroups responsible and implications for immunisation.A population based study of the impact of corticosteroid therapy and delayed diagnosis on the outcome of childhood pneumococcal meningitisClinical indicators of bacterial meningitis among neonates and young infants in rural KenyaGroup-A-streptococcal meningitis in a 7-year-old child--a rare pathogen in a non-immune compromised patient.Reference group choice and antibiotic resistance outcomes.Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern FranceNationwide Trends in Bacterial Meningitis before the Introduction of 13-Valent Pneumococcal Conjugate Vaccine-Burkina Faso, 2011-2013.Bacterial inhibition of phosphatidylcholine synthesis triggers apoptosis in the brain.Current concepts in the treatment of bacterial meningitis beyond the neonatal period.Early prediction of postmeningitic hearing loss in children using magnetic resonance imaging.Community-acquired urinary tract pathogens and their resistance patterns in hospitalized children in southeastern Ontario between 2002 and 2006.Pneumococcal meningitis in children: epidemiology, serotypes, and outcomes from 1997-2010 in UtahTreatment strategies for central nervous system infections.Pneumococcal pathogenesis: "innate invasion" yet organ-specific damage.Use of corticosteroids and other adjunct therapies for acute bacterial meningitis in adults.Treatment of bacterial meningitis: an update.Streptococcus pneumoniae infection: a Canadian perspective.Pneumococcal meningitis: clinical course and resource use in Western Australian children.Pneumococcal meningitis in Western Australian children: epidemiology, microbiology and outcome.Fever and stiff neck.The use of dexamethasone in bacterial meningitis in children and adults: a retrospective analysis.
P2860
Q27477819-A6BCA59F-E24C-4F35-9E14-2D63A85A398CQ28364129-6A4A72D8-E9A3-4B55-B4AA-3765D1BF3B10Q30431101-C134818C-5C6A-48D6-9038-D5E3926FB100Q30431534-1BD24F98-8517-4B6F-BABC-268FB96C820FQ33488557-D560628B-4379-437F-90DA-38E4E2A52B6BQ33745369-D2AE5E94-7E41-4D3F-B7AF-335F7C17F925Q33975374-A98AE992-E08E-44ED-8F98-DDD6D5FD5B0CQ33983338-6A0232B2-DD4F-47D7-A657-3EDBEAB0F20CQ34003220-C1DB19C0-F335-4C12-8236-2079AA1864A3Q34021766-1783F258-DA36-41AE-885E-5EE19553C1AEQ34031715-628AF950-7FCF-4DEF-A106-82D5190BA29BQ34033179-EF3DE8B7-A4F0-4637-99CB-0DBEF08D01C9Q34079508-D9A555A6-F76A-405C-9ADE-C38B382E923BQ34325877-B8FA7136-5106-4592-B5E5-ABED05B4DC03Q34519236-3C7B760F-91F6-4912-B268-BA61A1299E8AQ34539912-61B369B3-9328-462B-9FC5-268ABE9300FAQ34768547-93DB7D62-8190-4B70-892A-67E0588FA100Q34794716-420D17D5-6773-4C91-81FD-E04C247300D8Q35176266-F38AE344-002B-47EE-B24A-201554F9F12CQ35280351-A75D87A1-674B-4700-BB51-AC6C79746ADCQ35282963-60260BD6-2553-44EF-A776-FB68C839801CQ35555150-3A57C8F9-D73B-40B1-9466-81D359EFF7A1Q35588814-5A2AA241-06A0-4859-9830-CF09F1E168D5Q35880537-EF2EA526-B5FC-459F-8A03-79082258AAF8Q36155052-740C32B3-23E6-4580-89C2-4A263BE41A60Q36188733-D7FBD37E-2411-4CB3-A1C3-6AE64DED22F7Q36403935-B6FE4D43-BD6E-440E-946F-3B0D0D510BACQ36607421-B94B9A7C-5643-42E5-BF21-F1C4F595FE0CQ36895064-4C63E2EF-906F-4DF2-A830-592271E60366Q37015724-CD56ACE3-FEB1-471D-B335-D94454C51A18Q37422587-97F6D94C-D22F-4B8E-9509-87A378381D42Q37483938-AD9A7454-8886-4D82-A7FD-6BDA603A2CCEQ37693796-C2A9F4BF-0CEF-4252-BB83-BB796C66149FQ38017147-16A7ED14-F397-4404-8C21-87AE872F5A0AQ38044024-B04D34D8-1C8E-4E3E-A6E3-5D7FD187559DQ38131534-4B526CFC-C9D3-4916-A7A5-EE9208BAE023Q39697064-CBE48D1C-197D-4395-92D1-543DE5B2BFD5Q39697067-2A6B54DB-015A-421B-80C9-A11107127C0DQ40314179-6A6FF3B3-4B51-4B9F-9D76-CDB2A57D6A83Q40580834-D658DFCC-30F7-45EE-8D6D-59E9F83CD8AF
P2860
Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Three-year multicenter surveil ...... ibility and dexamethasone use.
@en
Three-year multicenter surveil ...... ibility and dexamethasone use.
@nl
type
label
Three-year multicenter surveil ...... ibility and dexamethasone use.
@en
Three-year multicenter surveil ...... ibility and dexamethasone use.
@nl
prefLabel
Three-year multicenter surveil ...... ibility and dexamethasone use.
@en
Three-year multicenter surveil ...... ibility and dexamethasone use.
@nl
P2093
P356
P1433
P1476
Three-year multicenter surveil ...... ibility and dexamethasone use.
@en
P2093
Bradley JS
Mason EO Jr
Schutze GE
P304
P356
10.1542/PEDS.102.5.1087
P407
P577
1998-11-01T00:00:00Z